Innovative non-animal human-based tools and strategies for biomedical research

Last updated: 16.7.2025
Grant

This Horizon Europe call supports research into innovative non-animal human-based tools and strategies for biomedical research. The program aims to accelerate the development of solutions that offer better translational value than traditional animal models, fostering a future with reduced animal use in biomedical science and improved health outcomes for patients. Projects are expected to contribute to the EU's leadership in health technology development and enhance societal impact through multidisciplinary approaches.

Who is Funded

This section details the eligibility criteria for applicants, the geographical scope of the program, and its overarching objectives. The program seeks to fund a diverse range of entities contributing to the advancement of biomedical research with a focus on non-animal methods across Europe and beyond, aiming to address critical public health challenges.

What is Funded

This section outlines the types of projects, thematic areas, and activities that are eligible for funding under this program. It focuses on innovative biomedical research, particularly emphasizing the development and validation of human-based tools and strategies to improve disease understanding and treatment, while also detailing the funding mechanism.

Type and Scope of Funding

This section provides essential details about the financial structure of the program, including the type of funding instrument used and the expected funding amounts per project. It clarifies that support is provided through grants based on a lump sum model.

Conditions and Requirements

This section outlines the key conditions and requirements that applicants and beneficiaries must adhere to throughout the application and project implementation phases. It covers aspects from proposal submission guidelines to collaboration mandates and other important provisions.

Application Procedure

This section outlines the step-by-step application process and the methods used for evaluating proposals and notifying applicants. It provides an overview of how submissions are handled and how funding decisions are made.

This section identifies the foundational legal and official documents that authorize and govern the funding program, ensuring transparency and adherence to established European Union frameworks for research and innovation.

Similar Programs

#Non-animal biomedical research#Human-based tools#Biomedical research funding#Horizon Europe Health#Innovative health technologies#EU research grants#Alternative animal testing#Organoids in research#In-silico models#Micro-physiological systems#Disease prediction prevention treatment#Translational medicine#Health data space#Lump sum funding#Research and Innovation Actions

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

8,000,000 €

Allocated Budget

Allocated Budget:

EUR 25,000,000

Open Until

Open Until:

Closed

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union (Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden), Switzerland, United Kingdom, Turkey, Moldova, Other

Sectors

Sectors:

Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Information and Communication Technology, Software Development, Environmental and Climate Protection, Other

Beneficiaries

Beneficiaries:

Biomedical research, Health, Patients, Legislators and regulators

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Commercialization, Implementation, Policy Development

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

Managed By:

European Health and Digital Executive Agency (HaDEA)

Additional Partners:

European Commission's Joint Research Centre (JRC)

0 x 0
XS